Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS.
- DOI
- 10.1016/j.ebiom.2024.105554
- Published
- 2025 Feb
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2024.105554,
title = {Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS.},
author = {Bedia JS and Jacobs IJ and Ryan A and Gentry-Maharaj A and Burnell M and Singh N and Manchanda R and Kalsi JK and Dawnay A and Fallowfield L and McGuire AJ and Campbell S and Parmar MKB and Menon U and Skates SJ},
year = {2025},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2024.105554},
url = {https://doi.org/10.1016/j.ebiom.2024.105554}
}RIS
TY - JOUR TI - Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS. AU - Bedia JS AU - Jacobs IJ AU - Ryan A AU - Gentry-Maharaj A AU - Burnell M AU - Singh N AU - Manchanda R AU - Kalsi JK AU - Dawnay A AU - Fallowfield L AU - McGuire AJ AU - Campbell S AU - Parmar MKB AU - Menon U AU - Skates SJ PY - 2025 JO - EBioMedicine DO - 10.1016/j.ebiom.2024.105554 UR - https://doi.org/10.1016/j.ebiom.2024.105554 ER -
APA
JS, B., IJ, J., A, R., A, G., M, B., N, S., R, M., JK, K., A, D., L, F., AJ, M., S, C., MKB, P., U, M., & SJ, S. (2025). Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2024.105554
Source records
- pubmed · retrieved 2026-09-26T16:45:21.037Z